The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes
- 1 June 1993
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 5 (3) , 341-348
- https://doi.org/10.1016/0952-7915(93)90051-s
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- CD19: Lowering the Threshold for Antigen Receptor Stimulation of B LymphocytesScience, 1992
- Suppression of the Immune Response by a Soluble Complement Receptor of B LymphocytesScience, 1991
- Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.The Journal of Experimental Medicine, 1991
- Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.The Journal of Experimental Medicine, 1991
- TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins.Molecular and Cellular Biology, 1990
- In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.The Journal of Experimental Medicine, 1990
- Proliferation of resting B cells is modulated by CR2 and CR1Immunology Letters, 1989
- CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tail.The Journal of Experimental Medicine, 1988
- Immune Response of a Patient with Deficiency of the Fourth Component of Complement and Systemic Lupus ErythematosusNew England Journal of Medicine, 1979
- ROLE OF COMPLEMENT IN INDUCTION OF ANTIBODY PRODUCTION IN VIVOThe Journal of Experimental Medicine, 1974